Fig. 2From: Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMDSurvival and weight did not change in immunodeficient dyW mice compared to immuno-competent mouse models of LAMA2-CMD. Survival study curves of male (a) and female (b) wild-type, NOD Scid, dyW, and NODScid dyW. c Weekly weights throughout the life span of male and female (d) wild-type, NOD Scid, dyW, and NODScid dyWBack to article page